Dose-individualization Efficiently Maintains Sufficient Exposure to Methotrexate without Additional Toxicity in High-dose Methotrexate Regimens for Pediatric Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Dose-individualization Efficiently Maintains Sufficient Exposure to Methotrexate without Additional Toxicity in High-dose Methotrexate Regimens for Pediatric Acute Lymphoblastic Leukemia

Published:2022-07-21 Issue:4 Volume:42 Page:769-777
ISSN:2096-5230
Container-title:Current Medical Science
language:en
Short-container-title:CURR MED SCI

Author:

Shen Ya-qing,Wang Zhu-jun,Wu Xiao-yan,Li Kun,Wang Zhong-jian,Xu Wen-fu,Zhou Fen,Jin Run-ming

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s11596-022-2589-1.pdf

Reference28 articles.

1. Wijaya J, Gose T, Schuetz JD. Using pharmacology to squeeze the life out of childhood leukemia, and potential strategies to achieve breakthroughs in medulloblastoma treatment. Pharmacol Rev, 2020,72(3):668–691

2. Moricke A, Zimmermann M, Valsecchi MG, et al. Dexamethasone vs prednisone in induction treatment of pediatric all: Results of the randomized trial aieop-bfm all 2000. Blood, 2016,127(17):2101–2112

3. Howard SC, McCormick J, Pui CH, et al. Preventing and managing toxicities of high-dose methotrexate. Oncologist, 2016,21(12):1471–1482

4. Pui CH, Campana D, Pei DQ, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med, 2009,360(26):2730–2741

5. Pui CH, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: Results of total therapy study xiiib at st jude children’s research hospital. Blood, 2004,104(9):2690–2696

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study;British Journal of Haematology;2024-03-03

2. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia;European Journal of Pediatrics;2023-10-18

3. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia;2023-07-14

4. Target concentration achievement for efficacy and safety of patients with osteosarcoma treated with high‑dose methotrexate based on individual pharmacokinetics: A retrospective study;Oncology Letters;2022-12-29